Provided by Tiger Fintech (Singapore) Pte. Ltd.

Aethlon Medical

1.35
-0.2900-17.68%
Post-market: 1.35-0.0001-0.01%19:59 EDT
Volume:1.19M
Turnover:1.72M
Market Cap:3.51M
PE:-0.17
High:1.58
Open:1.38
Low:1.34
Close:1.64
52wk High:8.44
52wk Low:1.08
Shares:2.60M
Float Shares:2.22M
Volume Ratio:1.22
T/O Rate:53.35%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-8.0442
EPS(LYR):-38.8676
ROE:-207.29%
ROA:-63.64%
PB:1.02
PE(LYR):-0.03

Loading ...

Aethlon Medical assumed with a Neutral at H.C. Wainwright

TIPRANKS
·
Jul 07

Maxim Group Reaffirms Their Hold Rating on Aethlon Medical (AEMD)

TIPRANKS
·
Jun 28

Aethlon Medical reports FY25 EPS ($8.58) vs. ($38.87) last year

TIPRANKS
·
Jun 27

BRIEF-Aethlon Medical Announces Financial Results For Fourth Quarter 2025

Reuters
·
Jun 27

Aethlon Medical Q4 EPS $(3.70) Misses $(1.07) Estimate

Benzinga
·
Jun 27

Aethlon Medical Reports Fiscal Q4 2025 Net Loss of $13.4M, Operating Expenses Down by 26%

Reuters
·
Jun 27

Press Release: Aethlon Medical Announces Financial Results for the Fiscal Fourth Quarter Ended March 31, 2025, and Provides Corporate Update

Dow Jones
·
Jun 27

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Jun 26

Aethlon Medical Inc expected to post a loss of $1.01 a share - Earnings Preview

Reuters
·
Jun 25

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Jun 23

Aethlon Medical Inc. to Announce Fiscal Fourth Quarter Financial Results

Reuters
·
Jun 20

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Jun 20

Aethlon treats second patient with Hemopurifier in Australian clinical trial

TIPRANKS
·
Jun 18

Aethlon Medical Inc. Announces Progress in Hemopurifier® Cancer Trial with Second Patient Treated in Australia

Reuters
·
Jun 18

Aethlon Medical Announces New Pre-Clinical Data on Hemopurifier® for Long COVID at Keystone Symposium

Reuters
·
Jun 09

Aethlon Medical trading halted, news pending

TIPRANKS
·
Jun 07

Aethlon Medical Approves Reverse Stock Split Plan

TIPRANKS
·
Jun 05

Aethlon Medical Inc. Announces 1-for-8 Reverse Stock Split Effective June 9, 2025

Reuters
·
Jun 05

Aethlon Medical Inc. Announces New Clinical Study Highlighting Hemopurifier's Ability to Remove Platelet-Derived Extracellular Vesicles in Ongoing Oncology Trial

Reuters
·
May 14

Aethlon Medical Approves Key Stockholder Proposals

TIPRANKS
·
May 14